Switch to: References

Add citations

You must login to add citations.
  1. Informing materials: drugs as tools for exploring cancer mechanisms and pathways.Etienne Vignola-Gagné, Peter Keating & Alberto Cambrosio - 2017 - History and Philosophy of the Life Sciences 39 (2):10.
    This paper builds on previous work that investigated anticancer drugs as ‘informed materials’, i.e., substances that undergo an informational enrichment that situates them in a dense relational web of qualifications and measurements generated by clinical experiments and clinical trials. The paper analyzes the recent transformation of anticancer drugs from ‘informed’ to ‘informing material’. Briefly put: in the post-genomic era, anti-cancer drugs have become instruments for the production of new biological, pathological, and therapeutic insights into the underlying etiology and evolution of (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Ludwik Gross, Sarah Stewart, and the 1950s discoveries of Gross murine leukemia virus and polyoma virus.Gregory J. Morgan - 2014 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 48:200-209.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • From the Regulatory Vision of Cancer to the Oncogene Paradigm, 1975–1985.Michel Morange - 1997 - Journal of the History of Biology 30 (1):1 - 29.
    Download  
     
    Export citation  
     
    Bookmark   16 citations  
  • From replica to instruments: animal models in biomedical research.Pierre-Luc Germain - 2014 - History and Philosophy of the Life Sciences 36 (1):114-128.
    The ways in which other animal species can be informative about human biology are not exhausted by the traditional picture of the animal model. In this paper, I propose to distinguish two roles which laboratory organisms can have in biomedical research. In the more traditional case, organisms act as surrogates for human beings, and as such are expected to be more manageable replicas of humans. However, animal models can inform us about human biology in a much less straightforward way, by (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • What mechanisms can’t do: Explanatory frameworks and the function of the p53 gene in molecular oncology.Alessandro Blasimme, Paolo Maugeri & Pierre-Luc Germain - 2013 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 44 (3):374-384.
    What has been called the new mechanistic philosophy conceives of mechanisms as the main providers of biological explanation. We draw on the characterization of the p53 gene in molecular oncology, to show that explaining a biological phenomenon implies instead a dynamic interaction between the mechanistic level—rendered at the appropriate degree of ontological resolution—and far more general explanatory tools that perform a fundamental epistemic role in the provision of biological explanations. We call such tools “explanatory frameworks”. They are called frameworks to (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • From parts to mechanisms: research heuristics for addressing heterogeneity in cancer genetics.William Bechtel - 2019 - History and Philosophy of the Life Sciences 41 (3):27.
    A major approach to cancer research in the late twentieth century was to search for genes that, when altered, initiated the development of a cell into a cancerous state or failed to stop this development. But as researchers acquired the capacity to sequence tumors and incorporated the resulting data into databases, it became apparent that for many tumors no genes were frequently altered and that the genes altered in different tumors in the same tissue type were often distinct. To address (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Cancer.Anya Plutynski - 2019 - Stanford Encyclopedia of Philosophy.
    Cancer—and scientific research on cancer—raises a variety of compelling philosophical questions. This entry will focus on four topics, which philosophers of science have begun to explore and debate. First, scientific classifications of cancer have as yet failed to yield a unified taxonomy. There is a diversity of classificatory schemes for cancer, and while some are hierarchical, others appear to be “cross-cutting,” or non-nested. This literature thus raises a variety of questions about the nature of the disease and disease classification. Second, (...)
    Download  
     
    Export citation  
     
    Bookmark